Reversible Cerebral Vasoconstriction with Thunderclap Headache: A Case Report

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2019 Dec 6

PMID 31804357

Citations 1

Authors

Jae Young Ji

Ho Soon Jung

Sie Hyeon Yoo

Hee Dong Son

A Joo Kim

Affiliations

Soon will be listed here.

Abstract

Rationale: Reversible cerebral vasoconstriction syndrome (RCVS) is often accompanied by thunderclap headaches. Although symptoms usually resolve spontaneously within 2 months, it can cause fatal complications, such as cerebral hemorrhage, and is difficult to differentiate from a migraine and other headaches on the basis of symptoms and Imaging study. In this case report, we explore clinical findings and appropriate treatment methods for RCVS through the case study of a female patient who experienced severe headache upon defecation PATIENT CONCERNS:: A 42-year-old female patient complained of a severe throbbing headache with a Numeric Rating Scale (NRS) score of 10 after defecation. The pain subsided temporarily after treatment with diclofenac 75 mg and Tridol 50 mg propacetamol 1 g, but the headache returned upon defecation; soon after, the patient complained again of regular headaches at 4 to 6-hour intervals irrespective of defecation.

Diagnosis: Brain computed tomography (CT) and head and neck magnetic resonance angiography, performed during a headache episode, revealed no specific neurological findings. Blood analysis was also normal. Head and neck CT angiography, performed one month after the start of the headaches, revealed RCVS.

Interventions: Treatment commenced with pregabalin (150 mg), oxycodone HCl/naloxone (10/5 mg), Alpram (0.5 mg), milnacipran (25 mg), and frovatriptan 25 mg, but there was no improvement in the headaches. The patient received bilateral trigger point injections (TPI) in the temporal muscles on four occasions at the pain clinic.

Outcomes: Medication showed no effect, but after the patient received four sessions of bilateral TPI in the temporal muscles her NRS score eventually decreased from 10 to 2. The patient is currently continuing medication while still experiencing headaches at reduced intensities.

Lessons: RCVS is difficult to diagnose; moreover, it is difficult differentiate RCVS from other headaches. However, as it can cause fatal complications, it should not be overlooked. It is essential to consider diagnostic treatment for all types of headaches because RCVS can be accompanied by headaches originating from other causes.

Citing Articles

Reversible cerebral vasoconstriction syndrome: literature review.

Ribas M, Paticcie G, de Medeiros S, Veras A, Noleto F, Santos J Egypt J Neurol Psychiatr Neurosurg. 2023; 59(1):5.

PMID: 36647436 PMC: 9833030. DOI: 10.1186/s41983-023-00607-9.

References

Calabrese L, Gragg L, Furlan A . Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol. 1993; 20(12):2046-50. View

Ducros A, Bousser M . Thunderclap headache. BMJ. 2013; 346:e8557. DOI: 10.1136/bmj.e8557. View

Pizzolato R, Villani V, Prosperini L, Ciuffoli A, Sette G . Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study. J Headache Pain. 2011; 12(5):521-5. PMC: 3173619. DOI: 10.1007/s10194-011-0338-0. View

Fernandez-de-Las-Penas C, Ge H, Arendt-Nielsen L, Cuadrado M, Pareja J . The local and referred pain from myofascial trigger points in the temporalis muscle contributes to pain profile in chronic tension-type headache. Clin J Pain. 2007; 23(9):786-92. DOI: 10.1097/AJP.0b013e318153496a. View

Serdaru M, Chiras J, Cujas M, LHERMITTE F . Isolated benign cerebral vasculitis or migrainous vasospasm?. J Neurol Neurosurg Psychiatry. 1984; 47(1):73-6. PMC: 1027644. DOI: 10.1136/jnnp.47.1.73. View

Choi H, Lee M, Choi H, Chung C . Characteristics and demographics of reversible cerebral vasoconstriction syndrome: A large prospective series of Korean patients. Cephalalgia. 2017; 38(4):765-775. DOI: 10.1177/0333102417715223. View

Yoshioka S, Takano T, Ryujin F, Takeuchi Y . A pediatric case of reversible cerebral vasoconstriction syndrome with cortical subarachnoid hemorrhage. Brain Dev. 2012; 34(9):796-8. DOI: 10.1016/j.braindev.2012.01.001. View

Miller T, Shivashankar R, Mossa-Basha M, Gandhi D . Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. AJNR Am J Neuroradiol. 2015; 36(8):1392-9. PMC: 7964694. DOI: 10.3174/ajnr.A4214. View

Valenca M, Andrade-Valenca L, Bordini C, Speciali J . Thunderclap headache attributed to reversible cerebral vasoconstriction: view and review. J Headache Pain. 2008; 9(5):277-88. PMC: 3452202. DOI: 10.1007/s10194-008-0054-6. View

10.

Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser M . The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007; 130(Pt 12):3091-101. DOI: 10.1093/brain/awm256. View

11.

Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser M . Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke. 2010; 41(11):2505-11. DOI: 10.1161/STROKEAHA.109.572313. View

12.

Koopman K, Teune L, ter Laan M, Uyttenboogaart M, Vroomen P, De Keyser J . An often unrecognized cause of thunderclap headache: reversible cerebral vasoconstriction syndrome. J Headache Pain. 2008; 9(6):389-91. PMC: 3452086. DOI: 10.1007/s10194-008-0068-0. View

13.

Schwedt T . Chronic migraine. BMJ. 2014; 348:g1416. DOI: 10.1136/bmj.g1416. View

14.

Bayer-Karpinska A, Patzig M, Adamczyk C, Dimitriadis K, Wollenweber F, Dichgans M . Reversible cerebral vasoconstriction syndrome with concurrent bilateral carotid artery dissection. Cephalalgia. 2013; 33(7):491-5. DOI: 10.1177/0333102413479836. View

15.

. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9):629-808. DOI: 10.1177/0333102413485658. View

16.

Ducros A . Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012; 11(10):906-17. DOI: 10.1016/S1474-4422(12)70135-7. View

17.

Mawet J, Boukobza M, Franc J, Sarov M, Arnold M, Bousser M . Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology. 2013; 81(9):821-4. DOI: 10.1212/WNL.0b013e3182a2cbe2. View

18.

Baratloo A, Mirbaha S, Delavar Kasmaei H, Payandemehr P, Elmaraezy A, Negida A . Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. Korean J Pain. 2017; 30(3):176-182. PMC: 5532524. DOI: 10.3344/kjp.2017.30.3.176. View

19.

Bittel B, Husmann K . A Case Report of Thunderclap Headache with Sub-arachnoid Hemorrhage and Negative Angiography: A Review of Call-Fleming Syndrome and the use of Transcranial Dopplers in Predicting Morbidity. J Vasc Interv Neurol. 2012; 4(2):5-8. PMC: 3317281. View

20.

Robbins M, Kuruvilla D, Blumenfeld A, Charleston 4th L, Sorrell M, Robertson C . Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache. 2014; 54(9):1441-59. DOI: 10.1111/head.12442. View